1. Primary age-related tauopathy (PART): a common pathology associated with human aging

   • John F. Crary
   • John Q. Trojanowski
   • Peter T. Nelson

   Consensus Paper 28 October 2014 Pages: 755 - 766

   

2. Are cases with tau pathology occurring in the absence of Aβ deposits part of the AD-related pathological process?

   • Heiko Braak
   • Kelly Del Tredici

   Commentary 31 October 2014 Pages: 767 - 772

   

3. PART and SNAP

   • Clifford R. Jack Jr.

   Commentary Open access 08 November 2014 Pages: 773 - 776

4. Aβ immunotherapy for Alzheimer’s disease: effects on apoE and cerebral vasculopathy

   • Kenji Sakai
   • Delphine Boche
   • James A. R. Nicoll

   Original Paper 07 September 2014 Pages: 777 - 789

   

5. Experimental transmissibility of mutant SOD1 motor neuron disease

   • Jacob I. Ayers
   • Susan Fromholt
   • David R. Borchelt

   Original Paper 28 September 2014 Pages: 791 - 803

   

6. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

   • Staffan Holmqvist
   • Oldriska Chutna
   • Jia-Yi Li

   Original Paper 09 October 2014 Pages: 805 - 820

   

7. Zebrafish models of BAG3 myofibrillar myopathy suggest a toxic gain of function leading to BAG3 insufficiency

   • Avnika A. Ruparelia
   • Viola Oorschot
   • Robert J. Bryson-Richardson

   Original Paper 02 October 2014 Pages: 821 - 833

   

8. Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis

   • Manja Schubert
   • Debabrata Panja
   • Christian A. Vedeler

   Original Paper Open access 24 October 2014 Pages: 835 - 852

   

9. Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors

   • Joshua Mangerel
   • Aryeh Price
   • Uri Tabori

   Original Paper 15 October 2014 Pages: 853 - 862

   

10. Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells

    • Mark Barszczyk
    • Pawel Buczkowicz
    • Cynthia Hawkins

    Original Paper Open access 06 August 2014 Pages: 863 - 877

    

11. Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues

    • Anna Sophie Berghoff
    • Rupert Bartsch
    • Matthias Preusser

    Review 07 October 2014 Pages: 879 - 891

    

12. In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody

    • Walter Maetzler
    • Andrea Pilotto
    • Daniela Berg

    Correspondence 07 November 2014 Pages: 893 - 895

13. Erratum to: Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice

    • Amanda N. Sacino
    • Mieu Brooks
    • Benoit I. Giasson

    Erratum 09 October 2014 Pages: 897 - 898